Company Filing History:
Years Active: 2016-2024
Title: Innovations by Nir Kalkstein in Cancer Risk Evaluation
Introduction
Nir Kalkstein is a prominent inventor based in Herzlia, Israel, known for his significant contributions to the field of medical research. With a total of six patents to his name, Kalkstein has focused on developing methods that enhance the evaluation of cancer risks through innovative techniques.
Latest Patents
Kalkstein's latest patents include groundbreaking methods for evaluating the risk of lung cancer and gastrointestinal cancer. The lung cancer risk evaluation method involves generating a set of features from current blood test results collected from a target individual. This method utilizes classifiers derived from historical blood test results of other sampled individuals to assess the lung cancer risk accurately. The evaluation incorporates various blood test results, including white blood cell counts, biochemistry test results, and smoking history. Similarly, his gastrointestinal cancer risk evaluation method follows a comparable approach, generating features from current blood test results and employing classifiers to determine the risk for the target individual.
Career Highlights
Kalkstein's career is marked by his dedication to advancing medical research through innovative solutions. His work at Medial Research Ltd. has positioned him as a key figure in the development of cancer risk evaluation technologies. His patents reflect a commitment to improving diagnostic methods and enhancing patient outcomes.
Collaborations
Kalkstein collaborates with notable colleagues, including Yaron Kinar and Varda Shalev, who contribute to the research and development efforts at Medial Research Ltd. Their combined expertise fosters an environment of innovation and progress in the field of medical diagnostics.
Conclusion
Nir Kalkstein's contributions to cancer risk evaluation through his innovative patents demonstrate his commitment to improving healthcare outcomes. His work continues to influence the medical research landscape, paving the way for advancements in cancer diagnostics.